Investigating a treatment for Ross River virus infection is just one of the clinical research trials underway at Griffith University’s Clinical Trials Unit designed to improve patient care and health outcomes on the Gold Coast. It’s an arrangement made possible by the newly signed Memorandum of Understanding between Griffith and Gold Coast Health. The trial […]
The Institute for Glycomics has been delivering major translational outcomes from its research in recent months, which will be celebrated during Glycomics Week. Glycomics Week highlights the Institute’s growing significant research successes. The Institute recently announced partnerships with Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc., for a new Strep A vaccine that has the enormous potential to help millions, […]
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.